Springpath Expands Into EMEA to Meet Growing Demand for Hyperconvergence
22.10.2015 08:00 | Business Wire
Springpath, the pioneer in hyperconvergence software, today announced its expansion into Europe, the Middle East and Africa (EMEA) with the opening of the regional headquarters in ‘s-Hertogenbosch, the Netherlands and appointment of Johan Pellicaan as Vice President EMEA. The company also announced its first EMEA distribution agreement with Dupaco Distribution in the Netherlands.
Having launched earlier this year in the United States, Springpath’s expansion follows growing demand in the EMEA market for data centre optimisation as enterprises transition to Web-scale, software-defined infrastructure and look to exploit Infrastructure-as-a-Service capabilities.
Springpath offers the industry’s first subscription-based data platform for hyperconvergence that transforms standard servers into a single pool of computing and storage resources that scale elastically. Based on Springpath’s patent pending Hardware Agnostic Log-structured Objects (HALO), the company’s own architecture design, the Springpath Data Platform enables organisations to become more agile through IT infrastructure automation, eliminating storage siloes and reducing the cost of data centre modernisation. With Springpath, enterprises can take data centre infrastructure and converged systems to a new level of performance and efficiency, delivering hyper-efficient utilisation with self-monitoring and self-healing capabilities.
“EMEA is an important market for us. We have ambitious plans to develop our network across the region, expanding our operations and partner base to meet customer demand,” said Johan Pellicaan, Vice President EMEA, Springpath. “EMEA enterprise businesses are looking to address the limitations of their data centre environments in order to compete more innovatively and cost-effectively. Our aim is to help enterprises transform their operations to increase performance and manageability while reducing costs. The Springpath HALO architecture and data platform helps organisations accelerate the transition to Web-scale infrastructure to support the increasing demands of today’s IT workloads and speed of business.”
Recognised as the third wave in infrastructure development, following client/server and virtualisation, hyperconvergence is an important catalyst that is making DevOps a reality for the enterprise. Hyperconvergence software gives organisations the ability to achieve an agile and lean data centre environment for the continuous delivery of modern applications. According to IDC, the hyperconvergence market is expected to grow at 94 percent going into 2016, passing $1.5 billion worldwide.
Commenting on the appointment of Dupaco Distribution as the first EMEA distributor for Springpath, Erik Monninkhof, director and co-founder of Dupaco Distribution, said, “We are excited to add Springpath to our portfolio. The capabilities and functionality in hyperconvergence software will be a true added value for our partners. They are a ground-breaking company bringing a new wave of innovation to the data centre.”
Dupaco Distribution is a leading Value Added Distributor of software in the Dutch ICT market, supporting over 600 enterprise solution partners with pre (sales) process, training and consultancy. Dupaco Distribution provides a mix of open source and Linux / Unix products, as well as specific solutions for Microsoft environments and a portfolio of Saas/Cloud applications.
The Springpath Data Platform is available on a subscription basis for as low as €3.600 per server per year street pricing and supports:
- Servers from Cisco, Dell, Fujitsu, HP, Lenovo and SuperMicro
- Compute platforms like Docker containers, VMware vSphere, Microsoft Hyper-v and OpenStack KVM
- Workloads like Server Virtualization, Development and Test and virtual desktop infrastructure (VDI) including Citrix XenDesktop
To learn more about the Springpath Data Platform, please visit: http://www.springpathinc.com/.
Springpath is the pioneer in hyperconvergence software, turning standard servers of choice into a single pool of compute and storage resources. The Springpath Data Platform eliminates the need for network storage and intuitively integrates into existing management tools to maximize operational efficiency. Using adaptive scaling capabilities, customers can grow compute, caching or capacity resources independently, depending on their changing business needs. Springpath proactively monitors your infrastructure to ensure resilient, always-on availability. Using data management and optimization capabilities, Springpath customers experience transformative levels of resource utilization, accelerating the adoption of DevOps in their organization with truly agile IT infrastructure. For more information, visit www.springpathinc.com or follow us on Twitter @SpringpathInc.
Racepoint Global for Springpath
James Thorniley, +44 (0) 208 811 2124
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15 | Pressemelding
Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11 | Pressemelding
Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy
European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25 | Pressemelding
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the
IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00 | Pressemelding
IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman
PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03 | Pressemelding
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate
Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00 | Pressemelding
Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom